Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Mushroom gummies put to the test for sharper young minds

NCT ID NCT07766642

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 14, 2026 · Last updated Aug 14, 2026

Summary

This trial investigates whether a daily mushroom-based gummy supplement can help children aged 4-12 who struggle with focus, concentration, memory, or low energy. Over 8 weeks, 35 children will take the gummies each morning, while parents report on changes in focus, attention, sleep, gut health, and well-being. The children also complete computer-based cognitive tests to measure any improvements in mental performance.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Auri Super Mushroom Daily Gummies For Kids (dietary supplement)
What this could lead to
If the gummies improve focus and energy, they could offer a natural, non-prescription option for parents seeking to support their child's cognitive health.
What could go wrong
This is a small, early-stage, unblinded study with no placebo group, so results may be influenced by expectations and may not apply broadly. The supplement's effects on children are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

35 people

The number who actually took part.

Started

Mar 2026

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

4 to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Be male or female. * Be aged 4-12. * Parent(s) reporting that their child has been experiencing issues regarding any of the following for the past four weeks: Difficulty focusing, Poor concentration, or Poor memory. * Parent(s) who report that their child will be willing to complete cognitive assessments at regular intervals during the study. * Any child who is generally healthy - does not live with any uncontrolled chronic disease. * Parent(s) who are willing to follow the study protocol and support their child to complete all study actions. * Any child who has no planned changes to school schedule, sleep routines, or behavioral therapies during the study duration. * Anyone willing to refrain from introducing any new prescription medications, wellness products, supplements, or herbal remedies into their child's routine during the test period. * If the child has been taking any other products, supplements, or herbal remedies, they have been taking these consistently for at least three months. * Has had a stable diet and sleep schedule for at least four weeks prior to the study. * Enrolled in and currently attending school at baseline and for the duration of the study period. * Resides in the United States. Exclusion Criteria: * Any child with a neurodevelopmental condition or developmental delay, including autism spectrum disorder, intellectual disability, language disorder, uncontrolled anxiety or mood disorder, or dyslexia. * Previous diagnosis of Attention-deficit hyperactivity disorder (ADHD). * Any child currently undergoing any assessments for suspected neurodevelopmental conditions or developmental delay. * Any child diagnosed with epilepsy or a seizure disorder. * Any child diagnosed with a bleeding disorder. * Any child with any known allergies or hypersensitivities to any supplement product ingredients. * Any child with any chronic health conditions that could impact their participation in this study, such as cancer, mental health disorders, a history of serious illness in the last three months, or planned surgery during the study period. * Any parent or child currently testing, or planning on starting in the next eight weeks, a product for another research study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Difficulty focusing are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Memory Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Citruslabs

    Las Vegas, Nevada, 89101, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.